Lymphoma Survivor Takes Up Lifetime TV’s Challenge

Trina Pockett was pregnant and living in Southern California when she went in to the doctor to find out whether she was having a boy or a girl. You’re having a girl, they told her. Oh, and by the way, you also have Stage 3 Hodgkin’s lymphoma.



OK, they didn’t say it that rudely. Rather, she mentioned a lump in her neck, which when biopsied was confirmed for Hodgkin’s lymphoma. The cancer was in Stage 3 because being pregnant made noticing her cancer symptoms and seperating them from pregnancy much more difficult.



At 5 and a half months pregnant she began a rigorous 2 months of chemotherapy. She was induced 6 weeks earlier than her due date and gave birth to a healthy baby girl who weighed 4 lbs 8 ozs.



The experience has drastically changed her, and it prompted her to write in to Lifetime Television’s Clean State Challenge 2009. The Clean Slate Challenge is a contest by the channel that encourages women to take part in a life-changing experience in 2009.



For her part Pockett, not a runner by trade or hobby, will participate in the Leukemia and Lymphoma Society's Team in Training half marathon in San Diego on May 31, 2009.



You can see a video of Trina Pockett here, at Lifetime’s website.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap